Profile data is unavailable for this security.
About the company
Amniotics AB (publ) is a Sweden-based biotech company that develops cell therapy drugs based on mesenchymal stem cells from amniotic fluid in its in-house GMP licensed facility. Amniotics' own marker technology is used to identify and select stem cells for different tissue types; Lung (PulmoStem), Brain (CogniStem), Kidney (NephroStem), Skin (CutiStem). It allows for selecting the type of cell to be used for specific tissue. The company has developed a process - patented in all steps - which includes collection of amniotic fluid, with a medical device developed by Amniotics, followed by sorting and propagation of stem cells and packaging of product in ampoules in its own GMP facility. Amniotics is a technology and service provider to Universities, Hospitals, and the Biopharmaceutical industry.
- Revenue in SEK (TTM)0.00
- Net income in SEK-30.87m
- Incorporated2015
- Employees9.00
- LocationAmniotics AB (publ)Medicon Village, Scheelevagen 2LUND 223 63SwedenSWE
- Websitehttps://www.amniotics.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bio Vitos Pharma AB | 2.61m | -12.87m | 4.06m | 1.00 | -- | 1.17 | -- | 1.55 | -0.1738 | -0.1738 | 0.0216 | 0.1012 | 0.0978 | 0.0564 | 5.49 | 2,613,400.00 | -48.17 | -31.11 | -49.96 | -32.92 | 98.14 | -- | -492.58 | -1,026.76 | 5.48 | -- | 0.00 | -- | 126.97 | -- | 13.64 | -- | -- | -- |
| 2cureX AB | 155.00k | -30.82m | 4.65m | -- | -- | 0.3395 | -- | 29.98 | -1.75 | -1.75 | 0.0088 | 0.7777 | 0.0048 | -- | 0.0838 | -- | -95.89 | -38.21 | -108.66 | -43.48 | -6,889.68 | -22,153.06 | -19,883.23 | -38,685.30 | -- | -46.08 | -- | -- | 72.22 | -- | -3.52 | -- | -- | -- |
| QuiaPEG Pharmaceuticals Holding AB | 0.00 | -16.52m | 6.56m | 8.00 | -- | 0.4299 | -- | -- | -3.51 | -3.51 | 0.00 | 0.2047 | 0.00 | -- | -- | -- | -50.53 | -95.67 | -100.54 | -207.86 | -- | 262.59 | -- | -5,002.50 | -- | -15.34 | 0.00 | -- | -- | -- | 17.75 | -- | 47.06 | -- |
| Carbiotix AB (publ) | 1.70m | -14.55m | 7.64m | 10.00 | -- | 0.2842 | -- | 4.49 | -0.2357 | -0.2357 | 0.0196 | 0.1492 | 0.0658 | -- | 3.43 | 170,052.00 | -56.32 | -49.38 | -62.10 | -55.50 | 201.79 | 574.69 | -855.62 | -1,828.86 | -- | -45.74 | 0.00 | -- | 259.56 | -12.04 | -10.02 | -- | 13.64 | -- |
| Eurocine Vaccines AB | 32.00k | -13.93m | 9.00m | 3.00 | -- | -- | -- | 281.16 | -0.1267 | -0.1267 | 0.0003 | -0.0014 | 0.0072 | -- | 0.0134 | -- | -311.00 | -83.17 | -462.65 | -97.89 | -29,487.50 | -- | -43,525.00 | -- | -- | -818.29 | -- | -- | -- | -- | 8.95 | -- | -- | -- |
| Stayble Therapeutics AB | 0.00 | -23.63m | 9.83m | 2.00 | -- | 0.7638 | -- | -- | -0.7935 | -0.7935 | 0.00 | 0.4059 | 0.00 | -- | -- | 0.00 | -153.00 | -78.64 | -183.58 | -95.58 | -- | -- | -- | -- | -- | -- | 0.0619 | -- | -- | -- | 3.22 | -- | -- | -- |
| XP Chemistries AB | 443.13k | -7.84m | 11.02m | 2.00 | -- | 0.4625 | -- | 24.88 | -0.2479 | -0.2479 | 0.0098 | 0.2552 | 0.0164 | 3.25 | 18.68 | 221,565.00 | -29.04 | -- | -30.83 | -- | -1,116.68 | -- | -1,769.29 | -- | 4.72 | -- | 0.00 | -- | -37.14 | -- | -1.55 | -- | -- | -- |
| Amniotics AB (publ) | 0.00 | -30.87m | 11.48m | 9.00 | -- | 0.7326 | -- | -- | -0.0374 | -0.0374 | 0.00 | 0.0057 | 0.00 | -- | -- | 0.00 | -112.25 | -101.09 | -362.62 | -149.91 | -- | -- | -- | -- | 1.12 | -16.17 | 0.00 | -- | -- | -- | 35.75 | -- | -- | -- |
| Diagonal Bio AB | 23.00k | -10.97m | 12.82m | 4.00 | -- | 0.1156 | -- | 557.41 | -0.1772 | -0.1772 | 0.0004 | 0.2768 | 0.0008 | -- | 2.00 | 4,600.00 | -36.58 | -- | -47.91 | -- | -35,765.22 | -- | -47,713.04 | -- | 0.2476 | -27.65 | 0.00 | -- | -88.67 | -- | 27.75 | -- | -- | -- |
| AegirBio AB | 36.00k | -49.38m | 15.38m | 14.00 | -- | -- | -- | 427.13 | -1.97 | -1.97 | 0.0015 | -0.3413 | 0.0005 | -- | 0.0065 | 2,571.43 | -67.93 | -- | -82.25 | -- | 355.56 | -- | -137,155.60 | -- | 0.5183 | -43.57 | 1.40 | -- | -94.61 | -- | 83.55 | -- | -- | -- |
| Asarina Pharma AB (publ) | 0.00 | -12.83m | 16.98m | 2.00 | -- | 10.30 | -- | -- | -0.5666 | -0.5666 | 0.00 | 0.0728 | 0.00 | -- | -- | 0.00 | -111.87 | -61.25 | -157.85 | -71.89 | -- | -- | -- | -- | -- | -- | 0.3775 | -- | -- | -- | 3.43 | -- | -- | -- |
